Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Encompass Health Co. stock logo
EHC
Encompass Health
$121.01
+0.8%
$109.93
$82.74
$122.09
$12.20B0.91701,552 shs977,100 shs
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$14.15
-0.6%
$13.72
$6.62
$17.67
$1.22B1.26863,981 shs968,608 shs
Select Medical Holdings Co. stock logo
SEM
Select Medical
$15.32
+1.0%
$15.95
$14.03
$40.98
$1.95B1.4928,122 shs1.46 million shs
10x Genomics, Inc. stock logo
TXG
10x Genomics
$9.49
+1.6%
$8.46
$6.78
$24.76
$1.15B1.942.42 million shs4.65 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Encompass Health Co. stock logo
EHC
Encompass Health
+0.85%+1.91%+3.30%+20.88%+43.62%
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
-0.42%+4.58%+9.52%-3.94%+95.04%
Select Medical Holdings Co. stock logo
SEM
Select Medical
+1.38%+6.54%-16.10%-15.78%-54.15%
10x Genomics, Inc. stock logo
TXG
10x Genomics
+1.61%+16.16%+14.75%-11.23%-57.08%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Encompass Health Co. stock logo
EHC
Encompass Health
4.755 of 5 stars
2.65.01.75.04.02.51.3
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
2.056 of 5 stars
2.25.00.00.04.01.70.0
Select Medical Holdings Co. stock logo
SEM
Select Medical
4.9993 of 5 stars
3.43.02.54.84.24.24.4
10x Genomics, Inc. stock logo
TXG
10x Genomics
4.4161 of 5 stars
4.22.00.04.82.22.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Encompass Health Co. stock logo
EHC
Encompass Health
3.11
Buy$122.711.41% Upside
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
2.33
Hold$16.6717.79% Upside
Select Medical Holdings Co. stock logo
SEM
Select Medical
2.80
Moderate Buy$26.0069.71% Upside
10x Genomics, Inc. stock logo
TXG
10x Genomics
2.38
Hold$15.8166.57% Upside

Current Analyst Ratings Breakdown

Latest EHC, SEM, MD, and TXG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/27/2025
Encompass Health Co. stock logo
EHC
Encompass Health
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$122.00 ➝ $135.00
5/24/2025
10x Genomics, Inc. stock logo
TXG
10x Genomics
Weiss Ratings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell (E+) ➝ Sell (E+)
5/19/2025
10x Genomics, Inc. stock logo
TXG
10x Genomics
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$26.00 ➝ $18.00
5/15/2025
10x Genomics, Inc. stock logo
TXG
10x Genomics
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$14.00 ➝ $14.00
5/13/2025
10x Genomics, Inc. stock logo
TXG
10x Genomics
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$14.00 ➝ $12.00
5/12/2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$18.50 ➝ $16.00
5/12/2025
10x Genomics, Inc. stock logo
TXG
10x Genomics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSell ➝ Sell$7.50 ➝ $6.50
5/12/2025
10x Genomics, Inc. stock logo
TXG
10x Genomics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $15.00
5/10/2025
10x Genomics, Inc. stock logo
TXG
10x Genomics
Weiss Ratings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell (E+) ➝ Sell (E+)
5/9/2025
10x Genomics, Inc. stock logo
TXG
10x Genomics
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$12.00 ➝ $9.00
5/8/2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$19.00 ➝ $20.00
(Data available from 5/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Encompass Health Co. stock logo
EHC
Encompass Health
$5.51B2.21$9.16 per share13.21$27.72 per share4.37
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$1.98B0.62$2.88 per share4.91$8.91 per share1.59
Select Medical Holdings Co. stock logo
SEM
Select Medical
$5.22B0.38$2.91 per share5.26$12.07 per share1.27
10x Genomics, Inc. stock logo
TXG
10x Genomics
$624.66M1.87N/AN/A$5.81 per share1.63
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Encompass Health Co. stock logo
EHC
Encompass Health
$455.70M$4.8427.1322.922.318.48%17.56%7.06%8/4/2025 (Estimated)
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
-$60.41M-$1.01N/A10.561.74-4.92%15.47%5.64%8/5/2025 (Estimated)
Select Medical Holdings Co. stock logo
SEM
Select Medical
$243.49M$1.349.2810.870.643.23%14.04%3.32%8/7/2025 (Estimated)
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$182.63M-$1.30N/AN/AN/A-29.90%-25.40%-19.69%8/14/2025 (Estimated)

Latest EHC, SEM, MD, and TXG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$0.45-$0.36+$0.09-$0.28$131.91 million$154.88 million
5/6/2025Q1 2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$0.25$0.33+$0.08$0.24$451.44 million$458.36 million
5/1/2025Q1 2025
Select Medical Holdings Co. stock logo
SEM
Select Medical
$0.45$0.44-$0.01$0.44$1.40 billion$1.35 billion
4/24/2025Q1 2025
Encompass Health Co. stock logo
EHC
Encompass Health
$1.19$1.37+$0.18$1.48$1.43 billion$1.46 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Encompass Health Co. stock logo
EHC
Encompass Health
$0.680.56%-17.02%14.05%2 Years
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
N/AN/AN/AN/AN/A
Select Medical Holdings Co. stock logo
SEM
Select Medical
$0.251.63%+10.06%18.66%N/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A

Latest EHC, SEM, MD, and TXG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2025
Encompass Health Co. stock logo
EHC
Encompass Health
quarterly$0.170.59%7/1/20257/1/20257/15/2025
5/1/2025
Select Medical Holdings Co. stock logo
SEM
Select Medical
quarterly$0.06251.37%5/15/20255/15/20255/29/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Encompass Health Co. stock logo
EHC
Encompass Health
0.84
1.05
1.04
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
0.81
1.60
1.42
Select Medical Holdings Co. stock logo
SEM
Select Medical
1.37
1.13
1.13
10x Genomics, Inc. stock logo
TXG
10x Genomics
N/A
4.97
4.26

Institutional Ownership

CompanyInstitutional Ownership
Encompass Health Co. stock logo
EHC
Encompass Health
97.25%
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
97.71%
Select Medical Holdings Co. stock logo
SEM
Select Medical
89.48%
10x Genomics, Inc. stock logo
TXG
10x Genomics
84.68%

Insider Ownership

CompanyInsider Ownership
Encompass Health Co. stock logo
EHC
Encompass Health
2.00%
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
0.90%
Select Medical Holdings Co. stock logo
SEM
Select Medical
11.60%
10x Genomics, Inc. stock logo
TXG
10x Genomics
9.39%
CompanyEmployeesShares OutstandingFree FloatOptionable
Encompass Health Co. stock logo
EHC
Encompass Health
35,000100.80 million98.63 millionOptionable
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
7,85085.91 million84.16 millionOptionable
Select Medical Holdings Co. stock logo
SEM
Select Medical
53,800128.54 million104.69 millionOptionable
10x Genomics, Inc. stock logo
TXG
10x Genomics
1,240123.13 million108.91 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Encompass Health stock logo

Encompass Health NYSE:EHC

$121.01 +1.00 (+0.83%)
Closing price 05/30/2025 03:59 PM Eastern
Extended Trading
$119.66 -1.36 (-1.12%)
As of 05/30/2025 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

Pediatrix Medical Group stock logo

Pediatrix Medical Group NYSE:MD

$14.15 -0.08 (-0.56%)
Closing price 05/30/2025 03:59 PM Eastern
Extended Trading
$14.14 -0.01 (-0.04%)
As of 05/30/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Select Medical stock logo

Select Medical NYSE:SEM

$15.32 +0.15 (+0.99%)
Closing price 05/30/2025 03:59 PM Eastern
Extended Trading
$15.14 -0.18 (-1.14%)
As of 05/30/2025 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. The Concentra segment operates and provides occupational health centers, telemedicine platforms, onsite clinics, and contract services at employer worksites that deliver occupational health services, consumer health, physical therapy, and preventive care. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.

10x Genomics stock logo

10x Genomics NASDAQ:TXG

$9.49 +0.15 (+1.61%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$9.55 +0.06 (+0.63%)
As of 05/30/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.